FDA Gives Green Light to Wegovy®: First GLP-1 Therapy Approved for Treating MASH with Liver Fibrosis, Offering New Hope to Millions at Risk
By Team VOH
The US FDA has granted accelerated approval to Novo Nordisk’s Wegovy® (semaglutide 2.4 mg)